(0,<http://bio2rdf.org/drugbank_vocabulary:Refractivity>)
(1,<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)>)
(2,<http://bio2rdf.org/drugbank_vocabulary:Transporter>)
(3,<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)>)
(4,<http://bio2rdf.org/gi_vocabulary:Resource>)
(5,<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge>)
(6,<http://www.w3.org/2002/07/owl#ObjectProperty>)
(7,<http://bio2rdf.org/drugbank_vocabulary:Clearance>)
(8,<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight>)
(9,<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name>)
(10,<http://bio2rdf.org/drugbank_vocabulary:Mixture>)
(11,<http://www.w3.org/2000/01/rdf-schema#Resource>)
(12,<http://bio2rdf.org/pharmgkb_vocabulary:Resource>)
(13,<http://bio2rdf.org/dpd_vocabulary:Resource>)
(14,<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count>)
(15,<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count>)
(16,<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction>)
(17,<http://bio2rdf.org/kegg_vocabulary:Resource>)
(18,<http://bio2rdf.org/drugbank_vocabulary:Pharmacology>)
(19,<http://www.w3.org/2002/07/owl#Class>)
(20,<http://bio2rdf.org/drugbank_vocabulary:Unit>)
(21,<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name>)
(22,<http://bio2rdf.org/drugbank_vocabulary:Resource>)
(23,<http://bio2rdf.org/drugbank_vocabulary:LogP>)
(24,<http://bio2rdf.org/drugbank_vocabulary:Enzyme>)
(25,<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule>)
(26,<http://bio2rdf.org/drugbank_vocabulary:Caco2-Permeability>)
(27,<http://bio2rdf.org/genecards_vocabulary:Resource>)
(28,<http://bio2rdf.org/pdb_vocabulary:Resource>)
(29,<http://bio2rdf.org/drugbank_vocabulary:Target-Relation>)
(30,<http://bio2rdf.org/drugbank_vocabulary:Category>)
(31,<http://bio2rdf.org/drugbank_vocabulary:PKa>)
(32,<http://bio2rdf.org/drugbank_vocabulary:Patent>)
(33,<http://bio2rdf.org/genbank_vocabulary:Resource>)
(34,<http://bio2rdf.org/drugbank_vocabulary:Drug>)
(35,<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action>)
(36,<http://bio2rdf.org/drugbank_vocabulary:Indication>)
(37,<http://bio2rdf.org/drugbank_vocabulary:Substructures>)
(38,<http://bio2rdf.org/drugbank_vocabulary:InChIKey>)
(39,<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility>)
(40,<http://purl.org/dc/terms/Dataset>)
(41,<http://bio2rdf.org/drugbank_vocabulary:Salt>)
(42,<http://bio2rdf.org/drugbank_vocabulary:Carrier>)
(43,<http://bio2rdf.org/pubchem.substance_vocabulary:Resource>)
(44,<http://bio2rdf.org/atc_vocabulary:Resource>)
(45,<http://bio2rdf.org/chemspider_vocabulary:Resource>)
(46,<http://bio2rdf.org/hgnc_vocabulary:Resource>)
(47,<http://bio2rdf.org/drugbank_vocabulary:Half-life>)
(48,<http://bio2rdf.org/drugbank_vocabulary:Type>)
(49,<http://bio2rdf.org/ahfs_vocabulary:Resource>)
(50,<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)>)
(51,<http://bio2rdf.org/drugbank_vocabulary:Food-interaction>)
(52,<http://bio2rdf.org/drugbank_vocabulary:Synonym>)
(53,<http://bio2rdf.org/drugbank_vocabulary:Brand>)
(54,<http://bio2rdf.org/drugbank_vocabulary:Source>)
(55,<http://bio2rdf.org/gtp_vocabulary:Resource>)
(56,<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula>)
(57,<http://bio2rdf.org/drugbank_vocabulary:Bioavailability>)
(58,<http://bio2rdf.org/drugbank_vocabulary:Polarizability>)
(59,<http://bio2rdf.org/drugbank_vocabulary:Volume-of-distribution>)
(60,<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight>)
(61,<http://bio2rdf.org/drugbank_vocabulary:Route-of-elimination>)
(62,<http://bio2rdf.org/wikipedia_vocabulary:Resource>)
(63,<http://bio2rdf.org/genatlas_vocabulary:Resource>)
(64,<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity>)
(65,<http://bio2rdf.org/drugbank_vocabulary:Toxicity>)
(66,<http://bio2rdf.org/drugbank_vocabulary:LogS>)
(67,<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Relation>)
(68,<http://bio2rdf.org/drugbank_vocabulary:Carrier-Relation>)
(69,<http://bio2rdf.org/pubmed_vocabulary:Resource>)
(70,<http://bio2rdf.org/drugbank_vocabulary:Kingdom>)
(71,<http://bio2rdf.org/ndc_vocabulary:Resource>)
(72,<http://bio2rdf.org/pubchem.compound_vocabulary:Resource>)
(73,<http://bio2rdf.org/uniprot_vocabulary:Resource>)
(74,<http://www.w3.org/ns/dcat#Distribution>)
(75,<http://bio2rdf.org/drugbank_vocabulary:Melting-Point>)
(76,<http://bio2rdf.org/bindingdb_vocabulary:Resource>)
(77,<http://bio2rdf.org/drugbank_vocabulary:Manufacturer>)
(78,<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings>)
(79,<http://bio2rdf.org/drugbank_vocabulary:Group>)
(80,<http://bio2rdf.org/drugbank_vocabulary:Biotransformation>)
(81,<http://bio2rdf.org/drugbank_vocabulary:Boiling-Point>)
(82,<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five>)
(83,<http://bio2rdf.org/iuphar_vocabulary:Resource>)
(84,<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count>)
(85,<http://www.w3.org/2002/07/owl#DatatypeProperty>)
(86,<http://bio2rdf.org/drugbank_vocabulary:Transporter-Relation>)
(87,<http://bio2rdf.org/drugbank_vocabulary:Affected-organism>)
(88,<http://bio2rdf.org/chebi_vocabulary:Resource>)
(89,<http://bio2rdf.org/drugbank_vocabulary:InChI>)
(90,<http://bio2rdf.org/drugbank_vocabulary:Target>)
(91,<http://bio2rdf.org/drugbank_vocabulary:SMILES>)
(92,<http://bio2rdf.org/drugbank_vocabulary:Absorption>)
(93,<http://bio2rdf.org/uspto_vocabulary:Resource>)
(94,<http://bio2rdf.org/drugbank_vocabulary:Protein-binding>)
(95,<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point>)
(96,<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter>)
(97,<http://bio2rdf.org/drugbank_vocabulary:Pharmaceutical>)
